Unraveling a Rare Gynecological Mystery Giant Ovarian Serous Cystadenoma Masquerading as Pseudo Meigs Syndrome

Introduction:

In the ever-evolving field of gynecological research, unique clinical cases can provide profound insights. One such rare case explores a massive ovarian serous cystadenoma that mimicked malignancy due to its association with ascites and pleural effusion clinically recognized as Pseudo-Meigs Syndrome. This intriguing scenario was successfully managed in a low-resource setting, reminding clinicians of the importance of differential diagnoses.

Case Summary

  • An 18-year-old girl presented with progressive abdominal distension, mild abdominal pain, and shortness of breath.
  • Clinical examination and imaging revealed a giant right adnexal mass (18×19 cm) with moderate ascites and pleural effusion.
  • CA-125 was mildly elevated (54.5 U/ml).
  • Surgical intervention via right salpingo-oophorectomy was performed.
  • Histopathology confirmed a benign serous cystadenoma.
  • Postoperative imaging showed complete resolution of effusions, confirming Pseudo-Meigs Syndrome.

Understanding Pseudo Meigs Syndrome

Pseudo-Meigs syndrome refers to non-fibroma ovarian tumors serous cystadenomas, teratomas accompanied by pleural effusion and ascites. Unlike true Meigs syndrome (which involves fibromas), this condition can mimic malignancy.

  • Right-sided pleural effusion is most common due to transdiaphragmatic movement of fluid.
  • VEGF (vascular endothelial growth factor) may play a role in increased capillary permeability.
  • Differential diagnosis includes tuberculosis, ovarian malignancies, and heart or liver diseases.

External Reference

Further Reading and Resources

Clinical Significance

  • Timely identification of benign tumors can prevent unnecessary anxiety and overtreatment.
  • CA-125, although elevated, should be interpreted with caution in young women with benign conditions.
  • Surgical removal results in complete resolution of symptoms, supporting conservative management in young patients.

Call-to-Action

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.